Ninepoint Partners LP Danaher Corp Transaction History

Ninepoint Partners LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$247.06 - $1507.4 $402,213 - $2.45 Million	1,628 New	1,628 $420,000
Q1 2022 May 09, 2022	SELL	$257.27 - $315.76 $452,280 - $555,106	-1,758 Closed	0 $0
Q3 2021 Nov 02, 2021	SELL	$272.21 - $332.43 $63,152 - $77,123	-232 Reduced 11.66%	1,758 $535,000
Q2 2021 Aug 09, 2021	SELL	$225.08 - $271.69 $10,128 - $12,226	-45 Reduced 2.21%	1,990 $534,000
Q1 2021 May 07, 2021	BUY	$212.38 - $245.9 $432,193 - $500,406	2,035 New	2,035 $458,000
Q4 2020 Jan 28, 2021	SELL	$212.5 - $245.46 $408,850 - $472,265	-1,924 Closed	0 $0
Q3 2020 Oct 15, 2020	BUY	$177.16 - $215.33 $340,855 - $414,294	1,924 New	1,924 $414,000
Q4 2019 Jan 24, 2020	SELL	$133.47 - $153.48 $1.88 Million - $2.17 Million	-14,115 Closed	0 $0
Q3 2019 Oct 30, 2019	BUY	$135.4 - $146.47 $1.91 Million - $2.07 Million	14,115 New	14,115 $2.04 Million
Q2 2018 Aug 13, 2018	SELL	$96.1 - $103.24 $4.78 Million - $5.13 Million	-49,700 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$85.26 - $94.62 $59,682 - $66,234	700 Added 1.43%	49,700 $4.61 Million
Q3 2017 Nov 07, 2017	BUY	$79.29 - $88.45 $3.89 Million - $4.33 Million	49,000	49,000 $4.2 Million

2,508

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $171B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Ninepoint Partners LP, based on Form 13F filings with the SEC.

Stay updated on Ninepoint Partners LP with notifications on news.